wassermann irreductible

Clicks: 68
ID: 206220
1936
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #175 of 320 articles by views in european journal of cancer prevention : the official journal of the european cancer prevention organisation (ecp)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 320 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
La Sociedad Francesa de Dermatología y Sifilografía destinó durante el mes de mayo de 1932, bajo la presidencia del Profesor Pautrier, una sesión al estudio de las suerologías irreductibles. Schulmann y Levy comenzaron, con muy buen criterio, por definir lo que debíamos comprender bajo el nombre de suerología írreductible. Podemos hablar de suerología irreductible, dicen ellos, cuando las reacciones continúan positivas a pesar de un tratamiento intenso durante dos años, por lo menos, en ausencia de todo accidente cutáneo o mucoso, de toda manifestación visceral apreciable, en especial de todo síntoma neurológico, siendo indispensable que la punción lumbar sea normal.
Reference Key
gil1936revistawassermann Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Alvaro Salcedo Gil
Journal european journal of cancer prevention : the official journal of the european cancer prevention organisation (ecp)
Year 1936
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.